First Trust Capital Management’s Astria Therapeutics ATXS Stock Holding History

First Trust Capital Management’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-831,357	Closed	-$10.9M	–	184
2025 Q4	$10.9M	Buy	+831,357	New	+$9.93M	0.66%	43

First Trust Capital Management's ATXS Position: Q1 2026 in Review

First Trust Capital Management sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 831,357 shares — an estimated $10.9M sold.

First Trust Capital Management first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $10.9M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

First Trust Capital Management reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
First Trust Capital Management sold 831,357 Astria Therapeutics shares in Q1 2026, an estimated $10.9M.
First Trust Capital Management first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
First Trust Capital Management's Astria Therapeutics position peaked at $10.9M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on First Trust Capital Management's 13F filing for Q1 2026, filed 14 May 2026.